No Symptoms, Real Risk: What This STI Could Mean for Your Cancer Risk
I’ve noticed something as a mom with older kids, and as a blogger who reads way too much health news late at night. People still treat STI testing like it’s a character flaw instead of basic upkeep.
One of the most commonly reported STIs in the United States is Chlamydia. The 2024 national data lists 1,515,985 reported cases. Data from the CDC shows the overall count has dipped recently, but the infection is still widespread.
Picture a woman in her early 50s, recently divorced, dating again, feeling totally fine. No pain. No discharge. Nothing obvious. If she skips testing because she “doesn’t have symptoms,” she could carry an infection for a while without realizing it. That’s how this spreads, quietly.
Here’s the issue, the American Association for Cancer Research blog reported that a National Cancer Institute researcher linked a chlamydia-related blood antibody to about a doubling in ovarian cancer risk.
A risk signal, not a verdict
The key word in the above report is “associated,” not “proven to cause,” but it’s the kind of signal that makes scientists lean in, and it should make you lean in too.
The Journal of the National Cancer Institute found that antibodies tied to prior or current Chlamydia trachomatis infection were linked with a higher ovarian cancer risk across two independent populations. Other infections they measured did not show the same pattern, which is part of why this stood out.
Here’s the connection, Chlamydia can contribute to pelvic inflammatory disease. Sadly chronic inflammation is one of those things medicine keeps circling back to when a disease doesn’t have a single clear cause. Not a neat answer. Still, it’s a clue.
Chlamydia 101
MedlinePlus notes that chlamydia spreads through sexual contact, including vaginal, oral, or anal sex, and many people won’t feel sick at all. That’s the part that always surprises me, even now, because we’re trained to trust our bodies to “warn” us. Sometimes they don’t.
Symptoms can show up, though. Burning when you pee. Pain during sex. Discharge that feels off. Sometimes rectal pain or discharge. Sometimes nothing.
As the USPSTF put it, routine screening is aimed mainly at sexually active women 24 and younger, plus women 25 and older when risk is higher, like having a new partner, multiple partners, or a partner who has an STI.
That “25 and older” line matters for the 50-plus crowd, because dating patterns can change fast after a long marriage.
From a numbers standpoint, I get why people try to mentally sort infections into “young person problems.” Real life doesn’t work like that. The truth is that risk follows behavior, not birthdays.
Treatment and the 7-day rule
According to the CDC, the right antibiotics can cure chlamydia, but you still have to protect your partner while treatment kicks in.
If you get a single-dose medicine, you’re supposed to wait seven days before having sex, and if you’re on a seven-day course, you wait until you finish it. It’s simple, but very easy to mess up in the moment.
There’s another detail people miss. Repeat infections are common, and the CDC recommends getting tested again about three months after treatment. It might be annoying, but it’s worth it in this scenario.
Why does it matter for women over 50?
The CDC guidance says untreated chlamydia can lead to pelvic inflammatory disease, which can cause scarring, infertility, ectopic pregnancy, and long-term pelvic pain. Even if pregnancy isn’t on your radar anymore, chronic pelvic pain absolutely is. Nobody needs that extra misery.
And if you’re thinking, “I’d know if my partner had something,” I’ve worked in fast-paced, long-hour jobs to know that people don’t always respect their relationship status. That’s why testing exists.
More About:Women's Health